{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:21:13Z","timestamp":1782508873032,"version":"3.54.5"},"publisher-location":"Chichester, UK","reference-count":97,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000026","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"source":"Crossref","is-referenced-by-count":38,"title":["Routine versus selective antifungal administration for control of fungal infections in patients with cancer"],"prefix":"10.1002","author":[{"given":"Peter C","family":"G\u00f8tzsche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"key":"10.1002\/14651858.CD000026-BIB1|cit1","series-title":"Program and Abstracts of 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, 1981","first-page":"abstract 852","article-title":"Ketoconazole prophylaxis of fungal infections in the granulocytopenic patient: a double-blind, randomized controlled trial","author":"Acuna","year":"1981"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB2|cit2","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026-BIB3|cit3","first-page":"19","article-title":"Results of a randomized double-blind placebo controlled trial with ketoconazole in the prevention of fungal infection in children treated with high dose chemotherapy and BMT [abstract]","volume":"5 Suppl 2","author":"Hartmann","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"1-2","key":"10.1002\/14651858.CD000026-BIB4|cit4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0954-6820.1978.tb08410.x","article-title":"Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study","volume":"204","author":"Brincker","year":"1978","journal-title":"Acta Medica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD000026-BIB5|cit5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1439-0507.1983.tb03203.x","article-title":"Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment","volume":"26","author":"Brincker","year":"1983","journal-title":"Mykosen"},{"key":"10.1002\/14651858.CD000026-BIB6|cit6","first-page":"347","article-title":"Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study","volume":"13","author":"Caselli","year":"1990","journal-title":"Microbiologica"},{"key":"10.1002\/14651858.CD000026-BIB7|cit7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","year":"1989","journal-title":"The American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000026-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archinte.1984.00350200054006","article-title":"Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two","volume":"144","author":"Estey","year":"1984","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000026-BIB9|cit9","first-page":"1065","article-title":"[Empiric therapy with fluconazole in granulocytopenic patients with carcinoma or leukemia][Japanese]","volume":"47","author":"Fukuda","year":"1994","journal-title":"The Japanese Journal of Antibiotics"},{"key":"10.1002\/14651858.CD000026-BIB10|cit10","first-page":"S15","article-title":"Early AmBisome in febrile neutropenia in patients with haematological disorders","volume":"14 Suppl 5","author":"Goldstone","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB11|cit11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000239184","article-title":"Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team","volume":"40","author":"Chandrasekar","year":"1994","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB12|cit12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000026-BIB13|cit13","first-page":"645","article-title":"Prophylactic fluconazole and marrow transplantation [correspondence]","volume":"327","author":"Goodman","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"13","key":"10.1002\/14651858.CD000026-BIB14|cit14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB15|cit15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study","volume":"147","author":"Hansen","year":"1987","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000026-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/147.6.1060","article-title":"Ketoconazole and candidiasis: a controlled study","volume":"147","author":"Hughes","year":"1983","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026-BIB17|cit17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-002-0207-5","article-title":"Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia","volume":"9","author":"Kaptan","year":"2003","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB18|cit18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026-BIB19|cit19","first-page":"A10","article-title":"Failure of fluconazole prophylaxis to reduce mortality during treatment for refractory acute myeloid leukemia: a phase III multicenter study [abstract]","volume":"73 suppl 2","author":"Kern","year":"1996","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000026-BIB20|cit20","first-page":"A52, abstract 2","article-title":"Failure of fluconazole prophylaxis to reduce mortality during treatment for refractory acute myleoid leukemia: results of a phase III multicenter study","volume":"74 Suppl 1","author":"Kern","year":"1997","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000026-BIB21|cit21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.3.CO;2-C","article-title":"Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group","volume":"83","author":"Kern","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB22|cit22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1002\/14651858.CD000026-BIB23|cit23","first-page":"LM","article-title":"Antifungal prophylaxis in neutropenic pts (<1000\/mmc) with haematological malignancy: a double-blind trial to compare itraconazole oral solution (IOS) with placebo (PLA)","volume":"abstract","author":"Favero","year":"1997","journal-title":"37th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC); 28 Sept-1 Oct 1997; Toronto"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB25|cit24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1002\/14651858.CD000026-BIB24|cit25","series-title":"The Tenth International Symposium on Infections in the Immunocompromised Host. Davos, Switzerland, 21-24 June 1998","first-page":"Abstract 104","article-title":"A double-blind, randomized placebo-controlled trial of itraconazole capsules for antifungal prophylaxis in neutropenic patients","author":"Nucci","year":"1998"},{"key":"10.1002\/14651858.CD000026-BIB26|cit26","series-title":"Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), 38th Meeting, San Diego, Sept 24-27 1998","first-page":"Abstract J-102","article-title":"Itraconazole capsules versus placebo in the prophylaxis of fungal infections in neutropenic cancer patients: a double-blind, randomized study","author":"Nucci","year":"1998"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB27|cit27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1992.tb00945.x","article-title":"Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias","volume":"231","author":"Palmblad","year":"1992","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD000026-BIB28|cit28","series-title":"Blood","first-page":"Abstract No. 82","article-title":"A randomized phase III trial of low dose liposomal amphotericin B (L-AmB) as prophylaxis of invasive fungal infections (IFI) in neutropenic patients (pts)","author":"Penack","year":"2005"},{"issue":"8","key":"10.1002\/14651858.CD000026-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD000026-BIB30|cit30","first-page":"0376","article-title":"Low dose liposomal amphotericin B (L-AMB) as prophylaxis of invasive fungal infections in patients (pts) with prolonged neutropenia: preliminary results of a randomized phase III trial","volume":"abstract","author":"Penack","year":"2005","journal-title":"10th Congress of the European Hematology Association"},{"issue":"5","key":"10.1002\/14651858.CD000026-BIB31|cit31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026-BIB32|cit32","series-title":"Proceedings of the American Association of Cancer Research","first-page":"Abstract C-115","article-title":"Empiric antifungal therapy for cancer patients with prolonged fever and granulocytopenia","author":"Pizzo","year":"1980"},{"issue":"1","key":"10.1002\/14651858.CD000026-BIB33|cit33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD000026-BIB34|cit34","series-title":"32nd Interscience Conference of Antimicrobial Agents and Chemotherapy. American Society for Microbiology, 1992","first-page":"abstract 620","article-title":"Prophylactic use of low-dose amphotericin B (AMB) in bone marrow transplant (BMT) patients","author":"Riley","year":"1992"},{"issue":"6","key":"10.1002\/14651858.CD000026-BIB35|cit35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients","volume":"97","author":"Riley","year":"1994","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD000026-BIB36|cit36","first-page":"LM","article-title":"The impact of fluconazole (F) prophylaxis on fungal colonization and subsequent infection in cancer neutropenic patients","volume":"abstract","author":"Laverdiere","year":"1997","journal-title":"37th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC); 28 Sept-1 Oct 1997; Toronto"},{"key":"10.1002\/14651858.CD000026-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/46.6.1001","article-title":"Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients","volume":"46","author":"Laverdiere","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB38|cit38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/172.4.1035","article-title":"Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias","volume":"172","author":"Schaffner","year":"1995","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026-BIB40|cit40","series-title":"23rd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, 1982","first-page":"abstract 166","article-title":"Prophylactic ketoconazole for the prevention of fungal infection in bone marrow transplant patients","author":"Siegel","year":"1982"},{"key":"10.1002\/14651858.CD000026-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000026-BIB42|cit42","series-title":"32nd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, 1992","first-page":"abstract 623","article-title":"Fluconazole prophylaxis in marrow transplant recipients: a randomized placebo controlled double blind study","author":"Slavin","year":"1992"},{"issue":"6","key":"10.1002\/14651858.CD000026-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"The Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000026-BIB44|cit44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2007.03.005","article-title":"Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation","volume":"13","author":"Upton","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB45|cit45","first-page":"195","article-title":"[A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B][Japanese]","volume":"21","author":"Suda","year":"1980","journal-title":"[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology"},{"issue":"3","key":"10.1002\/14651858.CD000026-BIB46|cit46","first-page":"1833","article-title":"Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies","volume":"26","author":"Tollemar","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD000026-BIB48|cit47","first-page":"1495","article-title":"Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients","volume":"25","author":"Tollemar","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD000026-BIB49|cit48","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplantation"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000026-BIB47|cit49","first-page":"S151","article-title":"Double-blind randomized trials with AmBisome (TM) as prophylaxis in bone marrow and liver transplant patients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplantation"},{"issue":"5-6","key":"10.1002\/14651858.CD000026-BIB50|cit50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leukemia & Lymphoma"},{"issue":"6","key":"10.1002\/14651858.CD000026-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole","volume":"83","author":"Wingard","year":"1987","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB52|cit52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD000026-BIB53|cit53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"835","key":"10.1002\/14651858.CD000026-BIB54|cit54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/pgmj.71.835.284","article-title":"Prophylactic use of fluconazole in neutropenic cancer patients","volume":"71","author":"Yamac","year":"1995","journal-title":"Postgraduate Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB55|cit55","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000026-BIB56|cit56","first-page":"24","article-title":"Prophylaxis of candidiasis in cancer patients","volume":"7 Suppl 6","author":"Bodey","year":"1990","journal-title":"Seminars in oncology"},{"key":"10.1002\/14651858.CD000026-BIB57|cit57","unstructured":"Brincker H Personal communication; unpublished study on fluconazole 1990"},{"issue":"3","key":"10.1002\/14651858.CD000026-BIB58|cit58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jama.1979.03300030030016","article-title":"Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study","volume":"242","author":"Ezdinli","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD000026-BIB59|cit59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-0142(19910701)68:1<9::AID-CNCR2820680103>3.0.CO;2-U","article-title":"Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia","volume":"68","author":"Hiddemann","year":"1991","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000026-BIB60|cit60","doi-asserted-by":"crossref","unstructured":"Prentice AG Bradford GR Prophylaxis of fungal infections with itraconazole during remission-induction therapy Mycoses 1989 96-102 (describes an unpublished study)","DOI":"10.1111\/j.1439-0507.1989.tb02298.x"},{"key":"10.1002\/14651858.CD000026-BIB61|cit61","first-page":"465, abstract 1","article-title":"Interim analysis of fluconazole (flu), intermittent amphotericin (ampho) and no treatment (ntx) for prophylaxis of fungal disease in bone marrow transplant (bmt) and acute leukemia (al) patients (pts)","volume":"12","author":"Reed","year":"1993","journal-title":"Proceedings of the Annual Meeting of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD000026-BIB62|cit62","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/clinids\/12.Supplement_3.S369","article-title":"Prophylaxis of oropharyngeal candidiasis with fluconazole","volume":"12 suppl 3","author":"Samonis","year":"1990","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026-BIB63|cit63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1990.tb07931.x","article-title":"Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children","volume":"76 Suppl 2","author":"Schaison","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD000026-BIB64|cit64","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s15010-006-5113-9","article-title":"A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II","volume":"34","author":"Schiel","year":"2006","journal-title":"Infection"},{"key":"10.1002\/14651858.CD000026-BIB65|cit65","series-title":"23rd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, 1982","first-page":"abstract 166","article-title":"Prophylactic ketoconazole for the prevention of fungal infection in bone marrow transplant patients","author":"Siegel","year":"1982"},{"issue":"5","key":"10.1002\/14651858.CD000026-BIB66|cit66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)","volume":"55","author":"Vehreschild","year":"2007","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB67|cit67","first-page":"389","article-title":"A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy","volume":"23","author":"Wang","year":"2003","journal-title":"Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA]"},{"key":"10.1002\/14651858.CD000026-BIB68|cit68","series-title":"46th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 Sept 27-30; San Francisco","article-title":"Evaluating voriconazole (VCZ) as primary antifungal prophylaxis during induction chemotherapy for acute myelogenous leukemia (AML)","author":"Cornely"},{"issue":"9270","key":"10.1002\/14651858.CD000026-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole","volume":"357","author":"Ahmad","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000026-BIB70|cit70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01621459.1989.10478782","article-title":"An assessment of publication bias using a sample of published clinical trials","volume":"84","author":"Berlin","year":"1989","journal-title":"Journal of the American Statistical Association"},{"key":"10.1002\/14651858.CD000026-BIB71|cit71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/sim.4780120517","article-title":"Interim analyses, stopping rules and data monitoring in clinical trials in Europe","volume":"2","author":"Buyse","year":"1993","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000026-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.1990.03440100121018","article-title":"Underreporting research is scientific misconduct","volume":"263","author":"Chalmers","year":"1990","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD000026-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000026-BIB74|cit74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-6-40","article-title":"Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents","volume":"6","author":"Due","year":"2006","journal-title":"BioMed Central Medical Research Methodology"},{"key":"10.1002\/14651858.CD000026-BIB75|cit75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V60.2.309.309","article-title":"Causes of initial remission induction failure in acute myelogenous leukemia","volume":"60","author":"Estey","year":"1982","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD000026-BIB76|cit76","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00558064","article-title":"Multiple publication of reports of drug trials","volume":"36","author":"G\u00f8tzsche","year":"1989","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000026-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(96)91115-0","article-title":"Pharmaceutical company trials and the integrity of medical research (letter)","volume":"347","author":"Huston","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000026-BIB78|cit78","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","article-title":"Causes of death in cancer patients","volume":"33","author":"Inagaki","year":"1974","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000026-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.282.18.1752","article-title":"Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis","volume":"282","author":"Johansen","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB80|cit80","article-title":"Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia","author":"Johansen","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB81|cit81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000239","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000026-BIB82|cit82","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000026-BIB83|cit83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004707.pub2","article-title":"Voriconazole versus amphotericin B in cancer patients with neutropenia","author":"J\u00f8rgensen","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000026-BIB84|cit84","first-page":"10","article-title":"Fungal infections in bone marrow transplant patients","volume":"17","author":"Meyers","year":"1990","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD000026-BIB85|cit85","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bjc.1978.284","article-title":"Size of cancer clinical trials and stopping rules","volume":"38","author":"Pocock","year":"1978","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD000026-BIB86|cit86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias, dimension of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000026-BIB87|cit87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.1986.4.10.1529","article-title":"Publication bias: the case for an international registry of clinical trials","volume":"4","author":"Simes","year":"1986","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD000026-BIB88|cit88","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007611-198607000-00020","article-title":"Clinical experience with amphotericin B in acute myelogenous leukemia","volume":"79","author":"Stein","year":"1986","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD000026-BIB89|cit89","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.315.7109.640","article-title":"Publication bias: evidence of delayed publication in a cohort study of clinical research projects","volume":"315","author":"Stern","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000026-BIB90|cit90","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026-BIB91|cit91","first-page":"43","article-title":"Role of surveillance cultures in prevention and treatment of fungal infections","volume":"9","author":"Walsh","year":"1990","journal-title":"Journal of National Cancer Institute Monographs"},{"issue":"3","key":"10.1002\/14651858.CD000026-BIB92|cit92","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/clinids\/13.3.496","article-title":"Empiric therapy with amphotericin B in febrile granulocytopenic patients","volume":"13","author":"Walsh","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026-BIB93|cit93","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/36.6.899","article-title":"Antifungal drug susceptibility testing","volume":"36","year":"1995","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000026-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"G\u00f8tzsche","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB95|cit95","article-title":"Antifungal prophylactic or empiric therapy versus placebo or no treatment in cancer patients with neutropenia","author":"G\u00f8tzsche","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2.","key":"10.1002\/14651858.CD000026-BIB96|cit96","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer (Cochrane Review)","author":"G\u00f8tzsche","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000026-BIB97|cit97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000026.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000026\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:13:51Z","timestamp":1704960831000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000026"}},"subtitle":[],"editor":[{"given":"Peter C","family":"G\u00f8tzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":97,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000026","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000026.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2002,4,22]]}}}